What’s Your InFLUence? The Evolving Role of Antiviral Therapy and Your Role in Management and Prevention of Seasonal Influenza

Release date: December 13, 2019
Expiration date: December 13, 2020
Estimated time to complete activity: 1.25 hour(s)

 

 

FACULTY

William A Fischer II, MD
Assistant Professor of Medicine
Division of Pulmonary and Critical Care Medicine
Institute of Global Health and Infectious Diseases
University of North Carolina
Chapel Hill, North Carolina

PROGRAM OVERVIEW

As influenza can impact both patients’ lives as well as workplace productivity this is an essential educational activity for all internal medicine or hospital-based clinicians. Given that influenza affects up to 15% of people annually, ensuring healthcare providers are fully prepared to diagnose and manage the infection with antiviral therapy is essential to optimizing outcomes. Further, healthcare providers would benefit from updates on the safety and efficacy of current and emerging antiviral agents in order to best comprehend the place of these agents in clinical practice. This slide and audio activity provides insights into the challenges of diagnosing and treating patients infected with the influenza virus and appropriate chemoprophylactic management of at-risk patients.

TARGET AUDIENCE

This activity is intended for urgent care clinicians, internal medicine clinicians and hospitalists, and all healthcare professionals involved with the diagnosis and management of patients with influenza.

LEARNING OBJECTIVES

Upon completion of this educational activity, participants should be able to:

  • Explain the importance of vaccination in preventing the spread of influenza and minimizing morbidity and mortality outcomes
  • Integrate guideline recommendations for the diagnosis of influenza into clinical practice
  • Apply knowledge of antiviral therapy and guideline recommendations to administer chemoprophylaxis to individuals at risk of influenza and associated complications
  • Appraise current and emerging antiviral agents for use in patients with influenza
DIRECTIONS TO LEARNER

There are no fees for participating and receiving CME credit for this activity. During the period of December 13, 2019 through December 13, 2020, participants must:

  • Read the learning objectives and faculty disclosures
  • Complete the pre-test
  • Study the educational activity
  • Complete the post-test and the evaluation form

A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed posttest with a score of 70% or better. Pharmacists must check the CPE monitor for their credits within 60 days of the activity.

MEDIA

Internet

ACCREDITATION STATEMENT

Integrity Continuing Education is accredited with commendation by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

DESIGNATION STATEMENT

Integrity Continuing Education, Inc. designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)TM .  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education

ACCREDITATION STATEMENT

Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Global Education Group designates this continuing education activity for 1.25 contact hour(s) (0.125 CEUs) of the Accreditation Council for Pharmacy Education.

Universal Activity Number – 0530-9999-19-253-H01-P

This is a knowledge-based activity.

Continuing Nursing Education

Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

DESIGNATION STATEMENT

This educational activity for 1.25 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

CONTACT INFORMATION

For information about ACCME accreditation of this activity, please contact Integrity Continuing Education at (855) 835-4004 or hmf@integrityce.com.

For information about ACPE or ANCC accreditation of this activity, please contact Global Education Group at 303-395-1782 or cme@globaleducationgroup.com.

DISCLOSURE OF CONFLICTS OF INTEREST

Integrity Continuing Education and Global Education Group require instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Integrity Continuing Education and Global Education Group for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Integrity Continuing Education and Global Education Group are committed to providing learners with high-quality CME/CE activities and related materials that promote improvement or quality in healthcare and not a specific proprietary business interest or a commercial interest.

William A Fischer II, MD
Speaker: Genentech

The following planners and managers, Patima Tanapat, PhD, Ashley Marostica, RN, MSN, Lindsay Borvansky, Andrea Funk, Ashley Cann, Liddy Knight, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group and Integrity CE do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

PRIVACY POLICY

When you participate in an online educational activity sponsored by Integrity Continuing Education, Inc., you will be asked for your name, degree(s), affiliation(s), street address, telephone number, fax number, and… (continued)

MINIMUM SYSTEM REQUIREMENTS

Windows 98, 2000, XP, 2003, Vista, and 7
Internet Explorer 6/7
Firefox 2
Mozilla 1.7 or higher
Netscape 8.1 or higher
Flash Player 10

Mac OS X 10.3, 10.4
Safari 1.3 (Mac OS 10.3)
Safari 2.0 or higher (Mac OS 10.4)
Firefox 2
Flash Player 10
Use of Internet Explorer browser is not recommended.

Click here for more information on minimum system requirements. 

DISCLAIMER

The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

PROVIDER STATEMENT

This CME activity is provided by Integrity Continuing Education.

This CE activity is jointly provided by Global Education Group and Integrity Continuing Education.

SUPPORTER ACKNOWLEDGEMENT

Supported by an educational grant from Genentech, Inc.

 

Continue to Pretest